SEC Form 4 · accession 0001225208-18-002058
BOSTON SCIENTIFIC CORP · BSX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ian T Meredith
Officer — EVP/ Global Chief Medical Offi
Period of report
Feb 1, 2018
Accepted (ET)
Feb 2, 2018 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885725
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 1, 2018 | M | 3,130 | $0.00 | A | 3,130 | D | |
| Common Stock | Feb 1, 2018 | F | 1,088 | $27.63 | D | 2,042 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Deferred Stock UnitsF1,F2 | — | Feb 1, 2018 | M | 3,130 | D | — | Feb 1, 2022 | Common Stock | 3,130 | 12,521 | D |
Explanation of responses
- F1Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
- F2Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 1, 2018, the first anniversary of the date of grant.
Remarks
meredithpoa.txt